{"id":906,"date":"2024-07-01T15:42:31","date_gmt":"2024-07-01T15:42:31","guid":{"rendered":"https:\/\/new.samev-dz.com\/?page_id=906"},"modified":"2024-07-01T15:42:31","modified_gmt":"2024-07-01T15:42:31","slug":"communications-presentees-9c2019","status":"publish","type":"page","link":"https:\/\/new.samev-dz.com\/index.php\/communications-presentees-9c2019\/","title":{"rendered":"Communications pr\u00e9sent\u00e9es 9C2019"},"content":{"rendered":"
\n

1\u00e8re s\u00e9ance : Syndrome d\u2019apn\u00e9es obstructives du sommeil<\/b><\/h2>\n

Conf\u00e9rence 1 Ob\u00e9sit\u00e9 et SAOS<\/b><\/a>
\nPr. Ayad<\/b><\/p>\n

Comm 2:<\/b>\u00a0Syndrome d\u2019apn\u00e9es obstructives du sommeil et syndrome m\u00e9tabolique<\/a>
\nH. Mahmoudi,<\/b>\u00a0N. Oumnia EHS Zemirli<\/p>\n

Comm 3:<\/b>\u00a0Prise en charge du syndrome ob\u00e9sit\u00e9-hypoventilation : \u00e0 propos de 40 observations<\/a>
\nH. Mahmoudi,<\/b>\u00a0N. Oumnia EHS Zemirli<\/p>\n<\/div>\n

 <\/p>\n

\n

2\u00e8me s\u00e9ance : Ob\u00e9sit\u00e9 et Risque Cardio-Vasculaire<\/b><\/h2>\n

Comm 4:\u00a0<\/b>Evaluation du profil lipidique chez des femmes ob\u00e8ses \u00e0 risque cardiovasculaire<\/a>
\nG.Hebboul,<\/b>\u00a0Z. D. Bouzenita 2, M. R. Guedjati 1 service de physiologie clinique m\u00e9tabolique et nutrition CHU Benflis Touhami Batna<\/p>\n

Comm 5:\u00a0<\/b>Le Syndrome m\u00e9tabolique et risque cardio-vasculaire chez une population de femmes ob\u00e8ses<\/a>
\nK. Lachekhab,<\/b>\u00a0M.R. Guedjati CHU Batna<\/p>\n

Comm 6:\u00a0<\/b>Les crit\u00e8res de choix lors de l\u2019identification des profils m\u00e9taboliques des femmes obeses<\/a>
\nM.R. Guedjati,<\/b>D. Gasmi physiologie clinique et explorations fonctionnelles m\u00e9tabolique et nutrition CHU Batna<\/p>\n

Comm 8:\u00a0<\/b>Effet d\u2019un protocole de r\u00e9entrainement \u00e0 intensit\u00e9 mod\u00e9r\u00e9e sur les param\u00e8tres bio-imp\u00e9dancem\u00e9triques et cardiorespiratoires chez des femmes obeses<\/a>
\nM.R. Guedjati<\/b>, Z. Bouznita physiologie clinique et explorations fonctionnelles m\u00e9tabolique et nutrition CHU Batna<\/p>\n

Conf\u00e9rence 2:\u00a0<\/b>Ob\u00e9sit\u00e9 et rein<\/a>
\nPr. Guermaz<\/b><\/p>\n<\/div>\n

 <\/p>\n

\n

3\u00e8me s\u00e9ance : Diab\u00e8te et RCV<\/b><\/h2>\n

Comm 9:<\/b>\u00a0L\u2019Homocyst\u00e9ine et l\u2019\u00e9quilibre diab\u00e9tique<\/a>
\nA. Belahadji<\/b>, S. Djeraba CHU Beni Messous Alger<\/p>\n

Comm 10:<\/b>\u00a0Le risque cardiovasculaire selon le genre au cours du diab\u00e8te de type 2 : similitudes et diff\u00e9rences<\/a>
\nM. Gourine<\/b>\u00a0m\u00e9decine interne CHU Oran<\/p>\n

Comm 11:<\/b>\u00a0L\u2019\u00e9paisseur intima media carotidienne : indicateur du risque cardiovasculaire chez des diab\u00e9tiques de type 2. Exp\u00e9rience de l\u2019h\u00f4pital militaire de Constantine<\/a>
\nH. Foudad<\/b>, 1 I. Bouaguel*,2 C. Guitari**, Y. Chettibi**, A. Trichine* cardiologie h\u00f4pital militaire Constantine HMRUC*, m\u00e9d. interne h\u00f4pital militaire Constantine HMRUC**<\/p>\n

Comm 12:<\/b>\u00a0Profil des diab\u00e9tiques de Type 2 ayant abaiss\u00e9 leur HBA1C suite \u00e0 un programme structur\u00e9 d\u2019\u00e9ducation th\u00e9rapeutique : une \u00e9tude comparative<\/a>
\nN. Lanasri<\/b>, A. Biad EPH Ain Taya<\/p>\n

Symposium NOVO NORDISK:<\/b>\u00a0VICTOZA<\/a>
\nPR. BERRAH<\/b><\/p>\n

Symposium SANOFI:<\/b>\u00a0DIABETE<\/a>
\nPR. CHAMI<\/b><\/p>\n<\/div>\n

 <\/p>\n

\n

4\u00e8me s\u00e9ance : HTA et RCV<\/b><\/h2>\n

Comm 13:<\/b>\u00a0La pr\u00e9hypertension en Alg\u00e9rie : facteurs d\u00e9terminants et profil cardiom\u00e9tabolique<\/a>
\nA. Mammeri<\/b>, M. Brouri, A. Tebaibia EPH Birtraria<\/p>\n

Comm 15:<\/b>Ath\u00e9roscl\u00e9rose infraclinique dans une population de coronariens hypertendus<\/a>
\nR. Merghit<\/b>, A. Trichine cardiologie H\u00f4pital universitaire de Constantine<\/p>\n

Symposium SANOFI HTA<\/b><\/a>
\n<\/b><\/p>\n<\/div>\n

 <\/p>\n

\n

5\u00e8me s\u00e9ance : Arteriopathies peripheriques<\/b><\/h2>\n

Conf\u00e9rence 3:<\/b>\u00a0Examen \u00e9chodoppler des art\u00e8res des membres inf\u00e9rieurs<\/a>
\nM. Dadon<\/b><\/p>\n

Comm 16:<\/b>\u00a0Pr\u00e9valence de l\u2019ath\u00e9rome carotidien chez les malades coronariens : R\u00e9sultats d\u2019une \u00e9tude transversale multicentrique \u00e0 l\u2019est Alg\u00e9rien<\/a>
\nR. Merghit<\/b>, A. Trichine cardiologie H\u00f4pital Universitaire de Constantine<\/p>\n

Comm 17:<\/b>\u00a0D\u00e9pistage de l\u2019art\u00e9riopathie oblit\u00e9rante asymptomatique des membres inf\u00e9rieurs par la mesure de l\u2019index de pression systolique dans un service de cardiologie : Exp\u00e9rience de l\u2019h\u00f4pital militaire de Constantine<\/a>
\nI. Bouaguel<\/b>, A. Trichine cardiologie h\u00f4pital militaire Constantine<\/p>\n

Comm 18:<\/b>\u00a0Pr\u00e9valence et facteurs pr\u00e9dictifs des art\u00e9riopathies p\u00e9riph\u00e9riques des membres inf\u00e9rieurs chez le diab\u00e9tique type 2<\/a>
\nF. Hocine<\/b>, S. Latreche, I. Bouaguel, A. Trichine, S. Benkhedda** cardiologie Constantine HMRUC *, cardiologie A2 CHU Mustapha Bacha Alger **<\/p>\n

Conf\u00e9rence 4:<\/b><\/p>\n

AOMI Nouveaux traitements en 2019<\/a>
\nLe traitement m\u00e9dical de l\u2019AOMI en 2019<\/a>
\nS.Zekri et JP. Laroche<\/b>
\nComm 28:<\/b>\u00a0Comment r\u00e9duire le risque cardio-vasculaire dans le traitement chirurgical de l\u2019art\u00e9riopathie diab\u00e9tique?<\/a>
\nS. Benallal<\/b>, M. N. Bouayed, Sidi Bel Abbes, Oran<\/p>\n

Comm 29:<\/b>\u00a0Pied diab\u00e9tique, de la revascularisation aux facteurs de croissance<\/a>
\nM. Bouzidi<\/b>, L. A. Bouziane, N. Moro, M.N. Bouayed Oran<\/p>\n

Comm 30:<\/b>\u00a0Chirurgie des St\u00e9noses de la carotide<\/a>
\nH. Hambli Hichem<\/b>, A. Nekhla chirurgie thoracique et vasculaire Tizi Ouzou<\/p>\n

Comm 31:<\/b>\u00a0Chirurgie des st\u00e9noses carotidiennes extracr\u00e2niennes : exp\u00e9rience du service de chirurgie vasculaire de l\u2019EHU Oran<\/a>
\n<\/b><\/p>\n<\/div>\n

 <\/p>\n

\n

6\u00e8me s\u00e9ance salle Chlef : Communications libres<\/b><\/h2>\n

Comm 19:<\/b>\u00a0Aspect clinique et \u00e9volutif de la thromboangeite oblit\u00e9rante<\/a>
\nK. Mesghouani<\/b>, R. Malek 1.med. Interne Constantine, 2. M\u00e9d. interne S\u00e9tif<\/p>\n

Comm 20:<\/b>\u00a0Approche diagnostique et th\u00e9rapeutique de la maladie de Leo Burger<\/a>
\nK. Mesghouani<\/b>, R. Malek 1.med. Interne Constantine, 2. M\u00e9d. interne S\u00e9tif<\/p>\n

Comm 21:<\/b>\u00a0Dysfonction \u00e9rectile : Marqueur de risque cardio vasculaire<\/a>
\nT. Rouag<\/b>\u00a0EH Skikda \/ EPH Collo<\/p>\n

Comm 22:<\/b>\u00a0Int\u00e9r\u00eat du pharmaco Echodoppler p\u00e9nien dans la dysfonction \u00e9rectile<\/a>
\nL. Atmani<\/b>\u00a0Alger<\/p>\n

Comm 23:<\/b>\u00a0R\u00f4le des marqueurs salivaires dans la progression des maladies cardiovasculaires chez les patients atteint d\u2019une parodontite agressive<\/a>
\nSenouci Salima<\/b>, Benmahdi Lahcen D\u00e9partement de pharmacie facult\u00e9 de m\u00e9decine Universit\u00e9 d\u2019Oran<\/p>\n

Comm 24:<\/b>\u00a0Angioscanner cardio-vasculaire en pratique : cas cliniques d\u00e9monstratifs<\/a>
\nM. I. Arfi<\/b>, Arezki Sid Ali, A. Bendib radiologie centrale CHU Mustapha Bacha Alger<\/p>\n

Comm 25:<\/b>\u00a0Apport de l\u2019angioscanner multid\u00e9tecteur dans l\u2019exploration des an\u00e9vrysmes de l\u2019aorte abdominale<\/a>
\nM. I. Arfi<\/b>A. Bendib, radiologie centrale CHU Mustapha Bacha Alger<\/p>\n

Comm 27:<\/b>La prise en charge du lymph\u0153d\u00e8me du membre sup\u00e9rieur secondaire au cancer du sein op\u00e9r\u00e9, le mot du m\u00e9decin MPR, Notre exp\u00e9rience depuis 2012<\/a>
\nZ. Boukara<\/b>, A.C. Nouar CHU Blida<\/p>\n<\/div>\n

 <\/p>\n

\n

7\u00e8me s\u00e9ance : La maladie veineuse chronique<\/b><\/h2>\n

Comm 28:<\/b>\u00a0Insuffisance Veineuse Superficielle, bien explorer les saph\u00e8nes et leur accessoires avant de traiter<\/a>
\nS.A. Belkaid<\/b>\u00a0Oran<\/p>\n

Comm 29:<\/b>\u00a0El\u00e9ment d\u00e9terminant de l\u2019examen \u00e9chodoppler pr\u00e9th\u00e9rapeutique de l\u2019insuffisance des veines saph\u00e8nes<\/a>
\nL. Moraglia<\/b>\u00a0Bordeaux<\/p>\n

Comm 30:<\/b>\u00a0La crossectomie est-elle justifi\u00e9e dans le traitement de la GVS ?<\/a>
\nN. Benmehidi<\/b><\/p>\n

Comm 31:<\/b>\u00a0Risques thrombotiques et scl\u00e9roth\u00e9rapie<\/a>
\nA. Hatri<\/b><\/p>\n

Comm 32:<\/b>\u00a0Complications thrombotiques post traitement thermique en do-veineuse des incontinences sapheniennes<\/a>
\nM. Baba Ahmed<\/b><\/p>\n

Comm 33:<\/b>\u00a0Donn\u00e9es \u00e9chodoppler et traitements des r\u00e9cidives variqueuses de la fosse poplit\u00e9e<\/a>
\nL. Moraglia<\/b>\u00a0Bordeaux<\/p>\n<\/div>\n

 <\/p>\n

\n

8\u00e8me s\u00e9ance : MTEV<\/b><\/h2>\n

Conf\u00e9rence 5:<\/b>\u00a0Le traitement de la MTE superficielle<\/a>
\nSophie Skopinsky<\/b>\u00a0CHU Bordeaux<\/p>\n

Comm 34:<\/b>\u00a0Thromboses veineuses des membres inf\u00e9rieurs (TVMI) en m\u00e9decine interne<\/a>
\nF. Zitouni<\/b>\u00a0H\u00f4pital Salim Zemirli<\/p>\n

Conf\u00e9rence 6:<\/b>\u00a0Actualit\u00e9s AOD et cancers<\/a>
\nH. Desmurs<\/b><\/p>\n

Conf\u00e9rence 7:<\/b>\u00a0AOD et AVK, ou en sommes-nous ?<\/a>
\nJ.P Laroche, S. Zekri<\/b><\/p>\n

Symposium SANOFI:<\/b>\u00a0THROMBOSE<\/a>
\nR. Guermaz<\/b><\/p>\n<\/div>\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

1\u00e8re s\u00e9ance : Syndrome d\u2019apn\u00e9es obstructives du sommeil Conf\u00e9rence 1 […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_bbp_topic_count":0,"_bbp_reply_count":0,"_bbp_total_topic_count":0,"_bbp_total_reply_count":0,"_bbp_voice_count":0,"_bbp_anonymous_reply_count":0,"_bbp_topic_count_hidden":0,"_bbp_reply_count_hidden":0,"_bbp_forum_subforum_count":0,"footnotes":""},"class_list":["post-906","page","type-page","status-publish","hentry"],"yoast_head":"\nCommunications pr\u00e9sent\u00e9es 9C2019 - Soci\u00e9t\u00e9 Alg\u00e9rienne de M\u00e9decine Vasculaire<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/new.samev-dz.com\/index.php\/communications-presentees-9c2019\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Communications pr\u00e9sent\u00e9es 9C2019 - Soci\u00e9t\u00e9 Alg\u00e9rienne de M\u00e9decine Vasculaire\" \/>\n<meta property=\"og:description\" content=\"1\u00e8re s\u00e9ance : Syndrome d\u2019apn\u00e9es obstructives du sommeil Conf\u00e9rence 1 [...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/new.samev-dz.com\/index.php\/communications-presentees-9c2019\/\" \/>\n<meta property=\"og:site_name\" content=\"Soci\u00e9t\u00e9 Alg\u00e9rienne de M\u00e9decine Vasculaire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/new.samev-dz.com\/index.php\/communications-presentees-9c2019\/\",\"url\":\"https:\/\/new.samev-dz.com\/index.php\/communications-presentees-9c2019\/\",\"name\":\"Communications pr\u00e9sent\u00e9es 9C2019 - Soci\u00e9t\u00e9 Alg\u00e9rienne de M\u00e9decine Vasculaire\",\"isPartOf\":{\"@id\":\"https:\/\/new.samev-dz.com\/#website\"},\"datePublished\":\"2024-07-01T15:42:31+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/new.samev-dz.com\/index.php\/communications-presentees-9c2019\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/new.samev-dz.com\/index.php\/communications-presentees-9c2019\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/new.samev-dz.com\/index.php\/communications-presentees-9c2019\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/new.samev-dz.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Communications pr\u00e9sent\u00e9es 9C2019\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/new.samev-dz.com\/#website\",\"url\":\"https:\/\/new.samev-dz.com\/\",\"name\":\"Soci\u00e9t\u00e9 Alg\u00e9rienne de M\u00e9decine Vasculaire\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/new.samev-dz.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Communications pr\u00e9sent\u00e9es 9C2019 - Soci\u00e9t\u00e9 Alg\u00e9rienne de M\u00e9decine Vasculaire","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/new.samev-dz.com\/index.php\/communications-presentees-9c2019\/","og_locale":"en_US","og_type":"article","og_title":"Communications pr\u00e9sent\u00e9es 9C2019 - Soci\u00e9t\u00e9 Alg\u00e9rienne de M\u00e9decine Vasculaire","og_description":"1\u00e8re s\u00e9ance : Syndrome d\u2019apn\u00e9es obstructives du sommeil Conf\u00e9rence 1 [...]","og_url":"https:\/\/new.samev-dz.com\/index.php\/communications-presentees-9c2019\/","og_site_name":"Soci\u00e9t\u00e9 Alg\u00e9rienne de M\u00e9decine Vasculaire","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/new.samev-dz.com\/index.php\/communications-presentees-9c2019\/","url":"https:\/\/new.samev-dz.com\/index.php\/communications-presentees-9c2019\/","name":"Communications pr\u00e9sent\u00e9es 9C2019 - Soci\u00e9t\u00e9 Alg\u00e9rienne de M\u00e9decine Vasculaire","isPartOf":{"@id":"https:\/\/new.samev-dz.com\/#website"},"datePublished":"2024-07-01T15:42:31+00:00","breadcrumb":{"@id":"https:\/\/new.samev-dz.com\/index.php\/communications-presentees-9c2019\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/new.samev-dz.com\/index.php\/communications-presentees-9c2019\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/new.samev-dz.com\/index.php\/communications-presentees-9c2019\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/new.samev-dz.com\/"},{"@type":"ListItem","position":2,"name":"Communications pr\u00e9sent\u00e9es 9C2019"}]},{"@type":"WebSite","@id":"https:\/\/new.samev-dz.com\/#website","url":"https:\/\/new.samev-dz.com\/","name":"Soci\u00e9t\u00e9 Alg\u00e9rienne de M\u00e9decine Vasculaire","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/new.samev-dz.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/new.samev-dz.com\/index.php\/wp-json\/wp\/v2\/pages\/906","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/new.samev-dz.com\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/new.samev-dz.com\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/new.samev-dz.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/new.samev-dz.com\/index.php\/wp-json\/wp\/v2\/comments?post=906"}],"version-history":[{"count":1,"href":"https:\/\/new.samev-dz.com\/index.php\/wp-json\/wp\/v2\/pages\/906\/revisions"}],"predecessor-version":[{"id":908,"href":"https:\/\/new.samev-dz.com\/index.php\/wp-json\/wp\/v2\/pages\/906\/revisions\/908"}],"wp:attachment":[{"href":"https:\/\/new.samev-dz.com\/index.php\/wp-json\/wp\/v2\/media?parent=906"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}